M

M.-C. Hsieh

Wan Fang Hospital

Publishes on Gastric Cancer Management and Outcomes, Intraperitoneal and Appendiceal Malignancies, Ovarian cancer diagnosis and treatment. 11 papers and 248 citations.

11Publications
248Total Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma.
C. -W. Wu, M.-C. Hsieh, Su-Shun Lo et al.|Gut|1996
Cited by 107Open Access

BACKGROUND: No nodal grouping category of gastric cancer has been universally accepted for the grading of the effectiveness of therapeutic regimens. AIMS: To establish an appropriate nodal grouping as a forecaster of distant disease and test its validity as a determinant in survival. PATIENTS: Five hundred and ten patients who underwent curative resections for gastric cancer were studied. METHODS: Retrospectively analyse the prognostic significance of the number of metastatic lymph nodes. RESULTS: A total of 17 176 lymph nodes with an average of 34 per specimen were removed, of which 2811 (16%) showed metastases. Among the 510 patients, 287 (56%) had lymph node metastases, with an average of 9.8 per metastatic case. The survival of all patients was related to their nodal status, an abrupt decrease in survival was seen between 0 and 1 and 4 compared with 5 or more modes while little difference in survival existed among 1, 2, 3, and 4, and among 5, 6, 7, and 8 positive nodes. Multivariate analysis showed that the number of positive nodes (1-4, 5-8 versus > or = 9; relative risk 2.2) and depth of cancer invasion (three levels; relative risk 1.9) were independently correlated with survival. The current nodal stage was not a prognostic factor. CONCLUSIONS: Gastric cancer patients with 0, 1 to 4, 5 to 8, and > 9 positive nodes may represent four appropriate prognostic groups and should be adopted for classification of nodal stage in gastric cancer.

Serum tumor necrosis factor in patients with gastric cancer.
C.-W. Wu, Chin Wen, M.-C. Hsieh et al.|PubMed|1998
Cited by 14

We have measured serum TNF-alpha levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no positive TNF-alpha value (> 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7%) had positive-TNF-alpha values. The proportion of TNF-alpha positive was 6.8% in stage I disease, 6.5% in stage II disease, 3.7% stage III, and 12.9% stage IV. No clinicopathologic factors were related to positive TNF-alpha value. TNF-alpha value was not an independent prognostic indicator The role of TNF-alpha in gastric cancer remains obscures.